These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 748797)

  • 1. Immunostimulation by cryosurgery: an orthotopic model of prostate and bladder cancer in the rat.
    Bonney WW; Henstorf JE; Emaus SP; Lubaroff DM; Feldbush TL
    Natl Cancer Inst Monogr; 1978 Dec; (49):375-81. PubMed ID: 748797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cryosurgery in prostate carcinoma: clinical evidence of immunostimulation of host versus tumor.
    Gonder MJ
    Natl Cancer Inst Monogr; 1978 Dec; (49):369. PubMed ID: 748795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunologic studies of prostatic cancer using the R3327 rat model.
    Lubaroff DM; Reynolds CW; Culp DA
    Trans Am Assoc Genitourin Surg; 1978; 70():60-5. PubMed ID: 753024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and histological findings of unsuspected prostatic adenocarcinoma in radical cystoprostatectomy for transitional cell carcinoma of the bladder.
    Moutzouris G; Barbatis C; Plastiras D; Mertziotis N; Katsifotis C; Presvelos V; Theodorou C
    Scand J Urol Nephrol; 1999 Feb; 33(1):27-30. PubMed ID: 10100360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunologic responsiveness & tumour growth of the Dunning R3327 rat prostatic adenocarcinoma following cryosurgery & orchiectomy.
    Eskandari H; Ablin RJ; Bhatti RA
    Indian J Exp Biol; 1982 Dec; 20(12):872-4. PubMed ID: 7183523
    [No Abstract]   [Full Text] [Related]  

  • 6. Urethral tumor recurrence following cystectomy and urinary diversion: clinical and pathological characteristics in 768 male patients.
    Stein JP; Clark P; Miranda G; Cai J; Groshen S; Skinner DG
    J Urol; 2005 Apr; 173(4):1163-8. PubMed ID: 15758728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transitional cell carcinoma involving the prostate with a proposed staging classification for stromal invasion.
    Esrig D; Freeman JA; Elmajian DA; Stein JP; Chen SC; Groshen S; Simoneau A; Skinner EC; Lieskovsky G; Boyd SD; Cote RJ; Skinner DG
    J Urol; 1996 Sep; 156(3):1071-6. PubMed ID: 8709310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CpG therapy is superior to BCG in an orthotopic bladder cancer model and generates CD4+ T-cell immunity.
    Mangsbo SM; Ninalga C; Essand M; Loskog A; Tötterman TH
    J Immunother; 2008 Jan; 31(1):34-42. PubMed ID: 18157010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryosurgical ablation of the normal ventral prostate plus adjuvant does not protect Copenhagen rats from Dunning prostatic adenocarcinoma challenge.
    Friedman EJ; Orth CR; Brewton KA; Ponniah S; Alexander RB
    J Urol; 1997 Oct; 158(4):1585-8. PubMed ID: 9302178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photodynamic therapy with PAD-S31, a new hydrophilic chlorin photosensitizer, in an orthotopic rat bladder tumor model.
    Asanuma H; Arai T; Morimoto Y; Kawauchi S; Satoh H; Seguchi K; Kikuchi M; Murai M
    J Urol; 2005 Nov; 174(5):2016-21. PubMed ID: 16217385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of synchronous triple primary carcinomas of the kidney, bladder and prostate].
    Satoh H; Momma T; Saito S; Hirose S
    Hinyokika Kiyo; 2003 May; 49(5):261-4. PubMed ID: 12822453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synchronous primary carcinomas of the bladder and prostate.
    Lee SH; Chang PL; Chen SM; Sun GH; Chen CL; Shen BY; Wu YS; Tsui KH
    Asian J Androl; 2006 May; 8(3):357-9. PubMed ID: 16625287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenocarcinoma R-3327 of the Copenhagen rat as a suitable model for immunological studies of prostate cancer.
    Lopez DM; Voigt W
    Cancer Res; 1977 Jul; 37(7 Pt 1):2057-61. PubMed ID: 301055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryosurgery for cancer.
    Gage AA
    Compr Ther; 1978 Feb; 4(2):24-30. PubMed ID: 75080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on a weakly immunogenic squamous cell carcinoma of the rat prostate.
    Lande IJ; Feldbush TL; Lubaroff DM
    Invest Urol; 1980 Mar; 17(5):419-24. PubMed ID: 7358506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orthotopic implantation of primary N-[4-(5-Nitro-2-furyl)-2-thiazolyl]formamide-induced bladder cancer in bladder submucosa: an animal model for bladder cancer study.
    Ibrahiem EH; Nigam VN; Brailovsky CA; Madarnas P; Elhilali M
    Cancer Res; 1983 Feb; 43(2):617-22. PubMed ID: 6848183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostatic capsule- and seminal-sparing cystectomy for bladder carcinoma: initial results for selected patients.
    Botto H; Sebe P; Molinie V; Herve JM; Yonneau L; Lebret T
    BJU Int; 2004 Nov; 94(7):1021-5. PubMed ID: 15541120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful diagnosis of orthotopic rat superficial bladder tumor model by ultrathin cystoscopy.
    Asanuma H; Arai T; Seguchi K; Kawauchi S; Satoh H; Kikuchi M; Murai M
    J Urol; 2003 Feb; 169(2):718-20. PubMed ID: 12544350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes of phenotypic expression of prostatic antigen in secondary transitional cell carcinoma of the prostate: evidence for induction phenomenon as a mechanism for acquisition of prostatic antigens in prostatic transitional cell carcinoma.
    Mai KT; Yazdi HM; Farmer J
    Prostate; 2001 May; 47(3):172-82. PubMed ID: 11351346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a novel transplantable orthotopic rat bladder transitional cell tumour model.
    Xiao Z; McCallum TJ; Brown KM; Miller GG; Halls SB; Parney I; Moore RB
    Br J Cancer; 1999 Oct; 81(4):638-46. PubMed ID: 10574249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.